Novavax (NVAX) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Novavax (NVAX) Reports In-Line Q3 EPS

Novavax Reports Third Quarter 2018 Financial Results

November 7, 2018 4:05 PM EST

Company to Host Conference Call Today at 4:30 p.m. ET

GAITHERSBURG, Md., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter and nine months ended September 30, 2018.

We remain on track to meet our 2018 objectives, as we continue to execute on our clinical milestones for ResVax and NanoFlu, said Stanley C. Erck, President and Chief Executive Officer of Novavax, Inc. In Prepare, our Phase 3 trial of ResVax, we will complete monitoring of the... More